CelLBxHealth PLC has secured a new statement of work worth approximately $65,000 with an existing US pharmaceutical customer. The deal involves processing around 100 patient samples using its Parsortix platform to isolate circulating tumour cells for molecular analysis, including mRNA. This contract extends an existing master services agreement and supports CelLBxHealth's strategy to grow recurring commercial opportunities and partnerships in the biopharmaceutical sector. The company aims to leverage growing demand for its technology in cancer research and drug development.
CelLBxHealth's recent contract worth about $65,000 adds to its recurring commercial opportunities in biopharma. For readers following the health sector, here is Pluang's market snapshot as of Oct 14, 2026 13:10 WIB: Among 128 priced US health stocks, 61 rose and 63 fell. Notable movers include Neurocrine Biosciences Inc (NBIX) at USD 134.80 with a 1-day change of -4.65% and a typical hold time of 24 days, ACADIA Pharmaceuticals Inc. (ACAD) at USD 18.51 down 4.64% with a 77-day hold time, and Erasca Inc. (ERAS) at USD 14.78 down 4.40% with a 1-day hold time and 100% sell order activity.
Vattenfall has contracted Fluence Energy to deliver a 254 MW, 1 GWh battery storage system at the Brunsbüttel site in Germany, set to be operational by the end of 2028. This project, one of Germany's largest battery storage facilities, will enhance g...
Shield appointed Michelle Clark, former HSBC surveillance leader, as Global Communications Surveillance Expert to enhance its AI-driven product strategy. Clark's 20+ years in global banking and expertise in regulatory compliance and AI innovation wil...
Phonak has introduced Roger On Sphere™, the world's first remote microphone using AI to separate speech from background noise in real time. This device enhances communication for people with hearing loss in noisy environments like restaurants and mee...
Southern Company, operating through Georgia Power, Alabama Power, and Mississippi Power, reported a data breach compromising customer personal information including names, addresses, Social Security numbers, and financial details. This breach raises ...
Intel's stock price has almost tripled in 2026, showing strong recent performance. However, a $10,000 investment in Intel made in 2016 would still be worth less than if it had been invested in the S&P 500 index. This highlights that despite recent ga...
